eISSN: 2473-0815
Submit manuscript...
Opinion Volume 13 Issue 2
Semaglutide and tirzepatide: A step towards the aetiological treatment of obesity
Ricardo V Garcia-Mayor
Received: August 12, 2025 | Published: September 5, 2025
Citation: Garcia-Mayor RV. Semaglutide and tirzepatide: A step towards the aetiological treatment of obesity. Endocrinol Metab Int J. 2025;13(2):63-64. DOI: 10.15406/emij.2025.13.00371
Abstract
Keywords: tirzepatide, semaglutide, aetiological, gastric balloons
©2025 Garcia-Mayor. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.